S
Stevanato Group
Pharmaceutical company committed to create systems, processes and services that guarantee the integrity of parenteral medicines
About Stevanato Group
Stevanato Group operates in the pharmaceutical and healthcare sectors, providing specialized analytical services focused on container performance, chemical analysis, and surface characterization. The company serves pharmaceutical manufacturers, biotech firms, and healthcare providers by ensuring the safety and efficacy of drug containers. Stevanato Group's business model revolves around offering tailored analytical solutions that help clients detect chemical interactions, understand container behavior, and investigate surface characteristics. Revenue is generated through service contracts and long-term partnerships with clients who require rigorous testing and validation of their products. The company stands out for its flexible and customized approach, adapting its services to meet specific client needs and regulatory requirements.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Jul 2025 | $200M | — | Banco BPM · BNL BNP Paribas · CDP | ↗ |
| POST IPO EQUITY✓Other financing | Mar 2024 | $330M | — | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Stevanato Group is 61K monthly website visits, up 84.8% over the last three months. Stevanato Group's team grew 60.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Stevanato Group in the Piombino Dese ecosystem
The Stevanato Group office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later5 investors entered at this stage
US Biomedical Advanced Research and Development Authority
BNP Paribas
CDP
Banco BPM
BNL BNP Paribas
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Stevanato Group on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Stevanato Group’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









